RBC Capital Assumes Pacira Pharmaceuticals (PCRX) at Outperform

April 6, 2021 4:27 PM EDT
Get Alerts PCRX Hot Sheet
Price: $60.39 -1.44%

Rating Summary:
    14 Buy, 13 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 14 | Down: 9 | New: 25
Trade Now! 
Join SI Premium – FREE

RBC Capital analyst Daniel Busb assumes coverage on Pacira Pharmaceuticals (NASDAQ: PCRX) with a Outperform rating and a price target of $86.00.

For an analyst ratings summary and ratings history on Pacira Pharmaceuticals click here. For more ratings news on Pacira Pharmaceuticals click here.

Shares of Pacira Pharmaceuticals closed at $68.89 yesterday.

You May Also Be Interested In

Related Categories

New Coverage